Enhabit (EHAB) Q2 EPS Jumps 86%
Earnings Performance: Enhabit (NYSE:EHAB) reported a Non-GAAP EPS of $0.13, exceeding expectations, with quarterly GAAP revenue of $266.1 million, marking a 2.1% increase from the previous year and surpassing analyst estimates.
Future Outlook: The company raised its full-year 2025 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, reflecting confidence in growth, particularly in the hospice segment, despite challenges in home health profitability and Medicare volumes.
Trade with 70% Backtested Accuracy
Analyst Views on EHAB
About EHAB
About the author
Enhabit (EHAB) to Participate in Bank of America Home Care Conference 2025
- Conference Participation: Enhabit will participate in the Bank of America Home Care Conference on December 9, which is expected to attract investor attention and enhance the company's visibility in the home health sector.
- Executive Attendance: President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in discussions, showcasing the leadership team's expertise and bolstering investor confidence.
- Live Webcast: The fireside chat will be webcast live, ensuring broader investor access and enhancing transparency while promoting interaction with stakeholders.
- Replay Availability: A replay will be available within 24 hours post-event, further expanding audience reach and aiding potential investors in understanding the company's strategic direction and market positioning.
Enhabit (EHAB) Receives Upgrade to Buy: Key Information You Need to Know
Zacks Rank Upgrade: Enhabit (EHAB) has been upgraded to a Zacks Rank #2 (Buy) due to a positive trend in earnings estimates, indicating potential for stock price increase.
Earnings Estimate Revisions: The Zacks Consensus Estimate for Enhabit has risen by 9.3% over the past three months, reflecting improved earnings outlook and business fundamentals.
Investment Strategy: The Zacks rating system, which maintains a balanced distribution of buy and sell ratings, suggests that stocks in the top 20% are likely to outperform the market based on earnings estimate revisions.
Market Implications: The upgrade positions Enhabit favorably for near-term price movement, as institutional investors often react to changes in earnings estimates, influencing stock valuations.
Enhabit Home Health & Hospice Sets Date for 2025 Q3 Earnings Call
Financial Reporting Announcement: Enhabit, Inc. will report its third-quarter financial results for the period ending September 30, 2025, on November 5, 2025, and will host a conference call on November 6, 2025, at 9 a.m. EST.
Company Overview: Enhabit Home Health & Hospice is a prominent national provider of home health and hospice services, operating 249 home health locations and 114 hospice locations across 34 states, focusing on advanced technology and compassionate care for patients.
Enhabit to Take Part in Jefferies 2025 Healthcare Services Conference
Company Announcement: Enhabit, Inc. will participate in the Jefferies 2025 Healthcare Services Conference, featuring a fireside chat with President and CEO Barb Jacobsmeyer and CFO Ryan Solomon on September 30 at 10:55 a.m. CT.
About Enhabit: Enhabit is a national home health and hospice provider with 249 home health and 114 hospice locations across 34 states, focusing on delivering patient care through advanced technology and compassionate teams.
Enhabit (EHAB) Q2 EPS Jumps 86%
Earnings Performance: Enhabit (NYSE:EHAB) reported a Non-GAAP EPS of $0.13, exceeding expectations, with quarterly GAAP revenue of $266.1 million, marking a 2.1% increase from the previous year and surpassing analyst estimates.
Future Outlook: The company raised its full-year 2025 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, reflecting confidence in growth, particularly in the hospice segment, despite challenges in home health profitability and Medicare volumes.
Enhabit Home Health & Hospice Announces CEO Transition Plan
Leadership Transition: Barb Jacobsmeyer, president and CEO of Enhabit, Inc., will step down in July 2026 or upon the appointment of a successor, with the board initiating a search for her replacement through Russell Reynolds Associates.
Company Overview: Enhabit is a prominent home health and hospice provider in the U.S., operating 249 home health locations and 114 hospice locations across 34 states, focusing on delivering high-quality patient care.
Enhabit (EHAB) to Participate in Bank of America Home Care Conference 2025
- Conference Participation: Enhabit will participate in the Bank of America Home Care Conference on December 9, which is expected to attract investor attention and enhance the company's visibility in the home health sector.
- Executive Attendance: President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in discussions, showcasing the leadership team's expertise and bolstering investor confidence.
- Live Webcast: The fireside chat will be webcast live, ensuring broader investor access and enhancing transparency while promoting interaction with stakeholders.
- Replay Availability: A replay will be available within 24 hours post-event, further expanding audience reach and aiding potential investors in understanding the company's strategic direction and market positioning.
Enhabit (EHAB) Receives Upgrade to Buy: Key Information You Need to Know
Zacks Rank Upgrade: Enhabit (EHAB) has been upgraded to a Zacks Rank #2 (Buy) due to a positive trend in earnings estimates, indicating potential for stock price increase.
Earnings Estimate Revisions: The Zacks Consensus Estimate for Enhabit has risen by 9.3% over the past three months, reflecting improved earnings outlook and business fundamentals.
Investment Strategy: The Zacks rating system, which maintains a balanced distribution of buy and sell ratings, suggests that stocks in the top 20% are likely to outperform the market based on earnings estimate revisions.
Market Implications: The upgrade positions Enhabit favorably for near-term price movement, as institutional investors often react to changes in earnings estimates, influencing stock valuations.
Enhabit Home Health & Hospice Sets Date for 2025 Q3 Earnings Call
Financial Reporting Announcement: Enhabit, Inc. will report its third-quarter financial results for the period ending September 30, 2025, on November 5, 2025, and will host a conference call on November 6, 2025, at 9 a.m. EST.
Company Overview: Enhabit Home Health & Hospice is a prominent national provider of home health and hospice services, operating 249 home health locations and 114 hospice locations across 34 states, focusing on advanced technology and compassionate care for patients.
Enhabit to Take Part in Jefferies 2025 Healthcare Services Conference
Company Announcement: Enhabit, Inc. will participate in the Jefferies 2025 Healthcare Services Conference, featuring a fireside chat with President and CEO Barb Jacobsmeyer and CFO Ryan Solomon on September 30 at 10:55 a.m. CT.
About Enhabit: Enhabit is a national home health and hospice provider with 249 home health and 114 hospice locations across 34 states, focusing on delivering patient care through advanced technology and compassionate teams.
Enhabit (EHAB) Q2 EPS Jumps 86%
Earnings Performance: Enhabit (NYSE:EHAB) reported a Non-GAAP EPS of $0.13, exceeding expectations, with quarterly GAAP revenue of $266.1 million, marking a 2.1% increase from the previous year and surpassing analyst estimates.
Future Outlook: The company raised its full-year 2025 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, reflecting confidence in growth, particularly in the hospice segment, despite challenges in home health profitability and Medicare volumes.
Enhabit Home Health & Hospice Announces CEO Transition Plan
Leadership Transition: Barb Jacobsmeyer, president and CEO of Enhabit, Inc., will step down in July 2026 or upon the appointment of a successor, with the board initiating a search for her replacement through Russell Reynolds Associates.
Company Overview: Enhabit is a prominent home health and hospice provider in the U.S., operating 249 home health locations and 114 hospice locations across 34 states, focusing on delivering high-quality patient care.
